| __timestamp | ImmunityBio, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1595000 | 47795223 |
| Thursday, January 1, 2015 | 11434000 | 50426000 |
| Friday, January 1, 2016 | 26546000 | 70853000 |
| Sunday, January 1, 2017 | 39778000 | 78168000 |
| Monday, January 1, 2018 | 53418000 | 123757000 |
| Tuesday, January 1, 2019 | 111997000 | 140963000 |
| Wednesday, January 1, 2020 | 139507000 | 131773000 |
| Friday, January 1, 2021 | 195958000 | 210328000 |
| Saturday, January 1, 2022 | 248149000 | 235780000 |
| Sunday, January 1, 2023 | 232366000 | 244990000 |
Unleashing the power of data
In the ever-evolving world of biotechnology, research and development (R&D) are the lifeblood of innovation. Over the past decade, ImmunityBio, Inc. and Travere Therapeutics, Inc. have been at the forefront of this innovation race. From 2014 to 2023, both companies have significantly increased their R&D budgets, reflecting their commitment to groundbreaking therapies.
ImmunityBio, Inc. started with a modest R&D expenditure in 2014, but by 2022, their investment had surged by over 15,000%, peaking at nearly 25% higher than their 2020 spending. Travere Therapeutics, Inc. mirrored this trend, with a consistent increase in R&D spending, culminating in a 400% rise over the same period.
This data underscores the relentless pursuit of innovation in the biotech sector, where companies are investing heavily to bring new treatments to market, ultimately aiming to improve patient outcomes worldwide.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
R&D Spending Showdown: Genmab A/S vs Travere Therapeutics, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Travere Therapeutics, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and ImmunityBio, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Analyzing R&D Budgets: Verona Pharma plc vs Travere Therapeutics, Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and Mesoblast Limited
Research and Development: Comparing Key Metrics for Protagonist Therapeutics, Inc. and Travere Therapeutics, Inc.
Analyzing R&D Budgets: Travere Therapeutics, Inc. vs Xencor, Inc.
R&D Insights: How Travere Therapeutics, Inc. and MiMedx Group, Inc. Allocate Funds